activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	3395897	CHEMBL1221007	Inhibition of human RIP3 autophosphorylation expressed in HEK293T cells	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	3395897	CHEMBL1221007	Inhibition of human RIP3 autophosphorylation expressed in HEK293T cells	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
	6385848	CHEMBL1838363	Inhibition of human RIPK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL1795199	Homo sapiens	INH	%	35.0
	6385849	CHEMBL1838363	Inhibition of human RIPK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL1795199	Homo sapiens	INH	%	35.0
	6385850	CHEMBL1838363	Inhibition of human RIPK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL1795199	Homo sapiens	INH	%	35.0
	6385851	CHEMBL1838363	Inhibition of human RIPK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL1795199	Homo sapiens	INH	%	35.0
	6385852	CHEMBL1838363	Inhibition of human RIPK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL1795199	Homo sapiens	INH	%	35.0
	12183819	CHEMBL2214442	Inhibition of RIPK3	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	pIC50		5.0
	15756829	CHEMBL3631113	Inhibition of RIPK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	81.43	CHEMBL1795199	Homo sapiens	INH	%	81.43
	15757894	CHEMBL3631113	Inhibition of RIPK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	83.06	CHEMBL1795199	Homo sapiens	INH	%	83.06
	15758873	CHEMBL3631113	Inhibition of RIPK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	27.61	CHEMBL1795199	Homo sapiens	INH	%	27.61
	16380173	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4ccncc4)n3c2)CC1		CHEMBL3735260	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
Not Determined	16380174	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CC1CN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4ccncc4)n3n2)CC(C)N1C		CHEMBL3735184		IC50			CHEMBL1795199	Homo sapiens	IC50		
	16380175	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	c1cc2c(c(-c3nc4cccnn4c3-c3ccncc3)c1)OCO2		CHEMBL3735309	=	IC50	nM	5500.0	CHEMBL1795199	Homo sapiens	IC50	uM	5.5
	16380176	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4ccccc4)n3n2)CC1		CHEMBL3734959	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380177	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4cccnc4)n3n2)CC1		CHEMBL3735077	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380178	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc(-c5ccsc5)c4)c(-c4ccncc4)n3n2)CC1		CHEMBL3735315	=	IC50	nM	300.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.3
	16380179	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc(-c5cccs5)c4)c(-c4ccncc4)n3n2)CC1		CHEMBL3735817	=	IC50	nM	270.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.27
	16380180	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc(-c5ccccc5)c4)c(-c4ccncc4)n3n2)CC1		CHEMBL3736408	=	IC50	nM	450.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.45
	16380181	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4ccc(-c5ccccc5)cc4)c(-c4ccncc4)n3n2)CC1		CHEMBL3735025	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380182	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CCOc1ccc2c(-c3nc4ccc(N5CCN(C)CC5)nn4c3-c3ccncc3)cccc2c1		CHEMBL3735563	=	IC50	nM	1700.0	CHEMBL1795199	Homo sapiens	IC50	uM	1.7
	16380183	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	COc1ccc2c(-c3nc4ccc(N5CCN(C)CC5)nn4c3-c3ccncc3)cccc2c1		CHEMBL3736103	=	IC50	nM	1200.0	CHEMBL1795199	Homo sapiens	IC50	uM	1.2
	16380184	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc5ccccc45)c(-c4ccncc4)n3n2)CC1		CHEMBL3735482	=	IC50	nM	880.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.88
	16380185	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4ccc5ncsc5c4)c(-c4ccncc4)n3n2)CC1		CHEMBL3734983	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380186	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4ccc5c(c4)OCCO5)c(-c4ccncc4)n3n2)CC1		CHEMBL3735428	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380187	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc5c4OCCO5)c(-c4ccncc4)n3n2)CC1		CHEMBL3735582	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380188	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4ccc5c(c4)OCO5)c(-c4ccncc4)n3n2)CC1		CHEMBL3735590	=	IC50	nM	7600.0	CHEMBL1795199	Homo sapiens	IC50	uM	7.6
	16380189	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc5c4OCO5)c(-c4ccncc4)n3n2)CC1		CHEMBL3735196	=	IC50	nM	2500.0	CHEMBL1795199	Homo sapiens	IC50	uM	2.5
	16380190	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	COc1cccc(-c2nc3ccc(N4CCN(C)CC4)nn3c2-c2ccncc2)c1		CHEMBL3735836	>=	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380299	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4cccc(C(=O)N5CCOCC5)c4)c(-c4ccncc4)n3n2)CC1		CHEMBL3735368	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380300	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4ccc(C(=O)N5CCOCC5)cc4)c(-c4ccncc4)n3n2)CC1		CHEMBL3734840	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16380301	CHEMBL3736773	Inhibition of full length human GST-tagged RIPK3 expressed in Spodoptera frugiperda Sf9 cells after 30 mins by scintillation and luminescence counting method in the presence of [gamma-33P]ATP	B	CN1CCN(c2ccc3nc(-c4ccc(-c5ccccc5)s4)c(-c4ccncc4)n3n2)CC1		CHEMBL3736271	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16431989	CHEMBL3750028	Inhibition of human RIPK3 using MBP substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	16638361	CHEMBL3825649	Inhibition of RIPK3 (unknown origin) preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	IC50	nM	16.0	CHEMBL1795199	Homo sapiens	IC50	nM	16.0
Not Active	16638362	CHEMBL3825650	Inhibition of RIPK3 (unknown origin) in HEK-293 cells assessed as necroptic cell death at 10 uM by cell-based assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Inactive	17935495	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935496	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	1274.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1274.0
Inactive	17935497	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935498	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935499	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935500	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935501	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	2177.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	2177.0
Inactive	17935502	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935503	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935504	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935505	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	2375.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	2375.0
Active	17935506	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	2664.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	2664.0
Inactive	17935507	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935508	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	161.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	161.0
Inactive	17935509	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935510	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935511	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935512	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	283.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	283.0
Inactive	17935513	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935514	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935515	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935516	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935517	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935518	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935519	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935520	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935521	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935522	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935523	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935524	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935525	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935526	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935527	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	=	Kd	nM	1696.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1696.0
Active	17935528	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	1171.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1171.0
Inactive	17935529	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935530	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935531	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935532	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935533	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935534	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	=	Kd	nM	2373.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	2373.0
Uncertain	17935535	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	1856.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1856.0
Inactive	17935536	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935537	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935538	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935539	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	1044.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1044.0
Inactive	17935540	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935541	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	=	Kd	nM	3637.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	3637.0
Inactive	17935542	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935543	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	662.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	662.0
Inactive	17935544	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935545	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	85.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	85.0
Active	17935546	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	=	Kd	nM	2079.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	2079.0
Inactive	17935547	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935548	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935549	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935550	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935551	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935552	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	=	Kd	nM	392.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	392.0
Active	17935553	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	1282.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1282.0
Inactive	17935554	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935555	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935556	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935557	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935558	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935559	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935560	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Kd	nM	368.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	368.0
Inactive	17935561	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935562	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	316.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	316.0
Inactive	17935563	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935564	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935565	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935566	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935567	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935568	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935569	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935570	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935571	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	1800.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1800.0
Active	17935572	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	6054.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	6054.0
Inactive	17935573	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935574	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	245.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	245.0
Inactive	17935575	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935576	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935577	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935578	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935579	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935580	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935581	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935582	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935583	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935584	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935585	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935586	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935587	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935588	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935589	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935590	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935591	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935592	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935593	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935594	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935595	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	324.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	324.0
Inactive	17935596	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935597	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935598	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935599	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935600	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935601	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935602	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935603	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935604	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935605	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935606	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935607	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935608	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935609	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935610	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935611	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935612	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935613	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935614	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935615	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935616	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935617	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935618	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935619	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935620	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935621	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935622	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	4820.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	4820.0
Inactive	17935623	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935624	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	6453.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	6453.0
Active	17935625	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	2459.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	2459.0
Inactive	17935626	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935627	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935628	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935629	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935630	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935631	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935632	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935633	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935634	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	506.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	506.0
Inactive	17935635	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935636	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935637	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935638	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935639	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935640	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935641	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935642	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	=	Kd	nM	1065.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1065.0
Inactive	17935643	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935644	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935645	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935646	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935647	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935648	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935649	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935650	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935651	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935652	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935653	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935654	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935655	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935656	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935657	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935658	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935659	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935660	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935661	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935662	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935663	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935664	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935665	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2254.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	2254.0
Inactive	17935666	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935667	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935668	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935669	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935670	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	1304.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1304.0
Inactive	17935671	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935672	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935673	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935674	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935675	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935676	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935677	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935678	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935679	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935680	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935681	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935682	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935683	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935684	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935685	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935686	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935687	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935688	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	366.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	366.0
Inactive	17935689	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935690	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	23.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	23.0
Inactive	17935691	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935692	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935693	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935694	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	3.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	3.0
Inactive	17935695	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935696	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935697	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935698	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935699	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935700	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	170.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	170.0
Inactive	17935701	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935702	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	=	Kd	nM	88.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	88.0
Inactive	17935703	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935704	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935705	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935706	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935707	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935708	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935709	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935710	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935711	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935712	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935713	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935714	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935715	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935716	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935717	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935718	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935719	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935720	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935721	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935722	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	1346.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1346.0
Inactive	17935723	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935724	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935725	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935726	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	1768.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	1768.0
Inactive	17935727	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935728	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935729	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935730	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935731	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935732	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935733	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Active	17935734	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Kd	nM	11.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	11.0
Inactive	17935735	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935736	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	3668.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	3668.0
Active	17935737	CHEMBL3991869	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	=	Kd	nM	967.0	CHEMBL1795199	Homo sapiens	Kd apparent	nM	967.0
Active	17953142	CHEMBL3993123	Inhibition of TNFalpha/z-VAD-FMK-induced RIP3 phosphorylation at Ser-227 residue in human HT-29 cells by Western blot method	B	CCC(C)(C)C(=O)N(O)Cc1ccccc1		CHEMBL4092421		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	17953147	CHEMBL3993110	Inhibition of full length recombinant human N-terminal GST-tagged RIP3 expressed in baculovirus infected sf9 cells at 1 uM using MBP as substrate preincubated for 15 mins followed by MBP/ATP mixture addition measured after 90 mins by ADP-Glo kinase assay	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	17953148	CHEMBL3993110	Inhibition of full length recombinant human N-terminal GST-tagged RIP3 expressed in baculovirus infected sf9 cells at 1 uM using MBP as substrate preincubated for 15 mins followed by MBP/ATP mixture addition measured after 90 mins by ADP-Glo kinase assay	B	CCC(C)(C)C(=O)N(O)Cc1ccccc1		CHEMBL4092421		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	17996192	CHEMBL4001361	Inhibition of human RIPK3	B	Cc1nc2nc(Oc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4085696		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	17996193	CHEMBL4001361	Inhibition of human RIPK3	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)c1ccccc1		CHEMBL4094680		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	17996194	CHEMBL4001361	Inhibition of human RIPK3	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4083528		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
	18111186	CHEMBL4024000	Inhibition of human RIPK3 at 10 uM using myelin basic protein as substrate in presence of [gamma33P]ATP relative to control	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2cc(C#N)ccc21		CHEMBL4100398	<	Inhibition	%	50.0	CHEMBL1795199	Homo sapiens	INH	%	50.0
	18211721	CHEMBL4045817	Inhibition of RIPK3 conserved Lys2 (DLKPSNVLLDPELHVK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-7.3	CHEMBL1795199	Homo sapiens	INH	%	-7.3
	18211962	CHEMBL4046058	Inhibition of RIPK3 conserved Lys2 (DLKPSNVLLDPELHVK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-4.9	CHEMBL1795199	Homo sapiens	INH	%	-4.9
	18275253	CHEMBL4118463	Inhibition of RIPK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNVLLDPELHVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-75.6	CHEMBL1795199	Homo sapiens	INH	%	-75.6
	18275254	CHEMBL4118463	Inhibition of RIPK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNVLLDPELHVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-72.2	CHEMBL1795199	Homo sapiens	INH	%	-72.2
	18275255	CHEMBL4118463	Inhibition of RIPK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPSNVLLDPELHVK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-60.7	CHEMBL1795199	Homo sapiens	INH	%	-60.7
	18277139	CHEMBL4119257	Inhibition of human RIPK3 assessed as residual activity at 16 uM relative to control	B	O=C1OC2(C(=O)Nc3ccccc32)C2=C1NCCS2(=O)=O		CHEMBL4126937	>	Activity	%	60.0	CHEMBL1795199	Homo sapiens	Activity	%	60.0
	18668216	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL4238971	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668217	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	O=C(O)CCCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4241699	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668218	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4244860	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668219	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	O=C1C2=C(C(=O)N1O)c1cn(c3ccccc13)CCCCCCn1cc2c2ccccc21		CHEMBL4243080	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668220	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	CCn1cc(C2=C(c3cn(C(C)C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4238883	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668221	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	CC(C)n1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4239321	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668222	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	CC(C)n1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4249393	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668223	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(CCCCCC(=O)O)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4240779	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668224	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4245590	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668225	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	CCn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4246062	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668226	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4241803	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668227	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4242235	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668228	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	O=C1C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ncccc23)C(=O)N1O		CHEMBL4238093	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668229	CHEMBL4234039	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(C)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL52851	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	18668357	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(C)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL52851	=	Activity	%	79.0	CHEMBL1795199	Homo sapiens	Activity	%	79.0
	18668358	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	O=C1C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ncccc23)C(=O)N1O		CHEMBL4238093	=	Activity	%	102.0	CHEMBL1795199	Homo sapiens	Activity	%	102.0
	18668359	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4242235	=	Activity	%	100.0	CHEMBL1795199	Homo sapiens	Activity	%	100.0
	18668360	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4241803	=	Activity	%	100.0	CHEMBL1795199	Homo sapiens	Activity	%	100.0
	18668361	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	CCn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4246062	=	Activity	%	102.0	CHEMBL1795199	Homo sapiens	Activity	%	102.0
	18668362	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4245590	=	Activity	%	105.0	CHEMBL1795199	Homo sapiens	Activity	%	105.0
	18668363	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	Cn1cc(C2=C(c3cn(CCCCCC(=O)O)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4240779	=	Activity	%	106.0	CHEMBL1795199	Homo sapiens	Activity	%	106.0
	18668364	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	CC(C)n1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4249393	=	Activity	%	97.0	CHEMBL1795199	Homo sapiens	Activity	%	97.0
	18668365	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	CC(C)n1cc(C2=C(c3cn(C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4239321	=	Activity	%	103.0	CHEMBL1795199	Homo sapiens	Activity	%	103.0
	18668366	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	CCn1cc(C2=C(c3cn(C(C)C)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4238883	=	Activity	%	107.0	CHEMBL1795199	Homo sapiens	Activity	%	107.0
	18668367	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	O=C1C2=C(C(=O)N1O)c1cn(c3ccccc13)CCCCCCn1cc2c2ccccc21		CHEMBL4243080	=	Activity	%	108.0	CHEMBL1795199	Homo sapiens	Activity	%	108.0
	18668368	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4244860	=	Activity	%	109.0	CHEMBL1795199	Homo sapiens	Activity	%	109.0
	18668369	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	O=C(O)CCCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)N(O)C2=O)c2ccccc21		CHEMBL4241699	=	Activity	%	100.0	CHEMBL1795199	Homo sapiens	Activity	%	100.0
	18668370	CHEMBL4234049	Inhibition of recombinant full length human RIPK3 expressed in baculovirus infected Sf9 insect cells assessed as residual activity at 10 uM using MBP as substrate in presence of [gamma-33P]ATP	B	N#CCCCCCn1cc(C2=C(c3cn(CCCCCC#N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL4238971	=	Activity	%	100.0	CHEMBL1795199	Homo sapiens	Activity	%	100.0
	18737869	CHEMBL4261376	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system by Kinomescan method	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	Kd	nM	7200.0	CHEMBL1795199	Homo sapiens	Kd	nM	7200.0
	18938269	CHEMBL4327861	Inhibition of human RIPK3 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	104.18	CHEMBL1795199	Homo sapiens	Activity	%	104.18
	18938270	CHEMBL4327861	Inhibition of human RIPK3 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	94.78	CHEMBL1795199	Homo sapiens	Activity	%	94.78
	18938706	CHEMBL4328225	Inhibition of human RIPK3 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	O=C1Nc2ccc(I)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL72365	<	Activity	%	65.0	CHEMBL1795199	Homo sapiens	Activity	%	65.0
Not Determined	18939091	CHEMBL4328589	Inhibition of human RIPK3 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL1795199	Homo sapiens	IC50		
	18939092	CHEMBL4328589	Inhibition of human RIPK3 using MBP as substrate by [gamma-33P]-ATP assay	B	O=C1Nc2ccc(I)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL72365	=	IC50	nM	5400.0	CHEMBL1795199	Homo sapiens	IC50	10'-6M	5.4
	19008081	CHEMBL4344880	Displacement of fluorescein labeled probe from full length human GST-tagged RIPK3 expressed in Sf9 cells incubated for 60 mins by HTRF assay	B	Nc1ccc(C#Cc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2N)nc1		CHEMBL4470115	=	IC50	nM	0.3	CHEMBL1795199	Homo sapiens	IC50	nM	0.3
	19008082	CHEMBL4344880	Displacement of fluorescein labeled probe from full length human GST-tagged RIPK3 expressed in Sf9 cells incubated for 60 mins by HTRF assay	B	Cc1ccc(COC(=O)Nc2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL4434926	=	IC50	nM	270.0	CHEMBL1795199	Homo sapiens	IC50	nM	270.0
	19008087	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	CC#Cc1c(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ccnc1N		CHEMBL4552106	=	IC50	nM	16.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.016
	19008088	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL509101	=	IC50	nM	180.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.18
	19008089	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	O=C(Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4455682	=	IC50	nM	2.9	CHEMBL1795199	Homo sapiens	IC50	uM	0.0029
	19008090	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	O=C(Nc1ccc(Oc2ccncc2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4572309	=	IC50	nM	400.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.4
	19008091	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	O=C(Nc1ccc(Oc2ccncc2)c(F)c1)c1cccc(-c2ccc(F)cc2)c1		CHEMBL4468222	>	IC50	nM	15000.0	CHEMBL1795199	Homo sapiens	IC50	uM	15.0
	19008092	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc(C)c1Oc1ccncc1		CHEMBL4542026	=	IC50	nM	320.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.32
	19008093	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccncc2)c1C		CHEMBL4434881	=	IC50	nM	180.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.18
	19008094	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	O=C(Nc1ccc(Oc2ccncc2)c2ccccc12)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4438939	=	IC50	nM	50.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.05
	19008095	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc1Oc1ccnc(NC(=O)C2CC2)c1		CHEMBL4476485	=	IC50	nM	8.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.008
	19008096	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc(C)c1Oc1ccnc(NC(=O)C2CC2)c1		CHEMBL4476076	=	IC50	nM	88.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.088
	19008097	CHEMBL4344883	Displacement of fluorescein labeled ATP probe from full length His/GST-tagged RIPK3 (unknown origin) incubated for 60 mins by HTRF assay	B	Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccnc(NC(=O)C3CC3)c2)c1C		CHEMBL4551490	=	IC50	nM	91.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.091
	19008132	CHEMBL4344888	Time dependent inhibition of full length His/GST-tagged RIPK3 (unknown origin) measured every 5 mins for 60 mins in presence of fluorescein labeled probe by HTRF assay relative to control	B	Nc1ccc(C#Cc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2N)nc1		CHEMBL4470115	=	FC		6.0	CHEMBL1795199	Homo sapiens	FC		6.0
Active	19041267	CHEMBL4352528	Inhibition of human RIPK3 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
	19092100	CHEMBL4366574	Inhibition of human RIPK3 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-2.23	CHEMBL1795199	Homo sapiens	INH	%	-2.23
	19146692	CHEMBL4378725	Inhibition of recombinant RIPK3 (unknown origin) using MBP as substrate preincubated for 15 mins followed by addition of MBP and measured after 120 min ADP-Glo kinase assay	B	CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(CC(=O)Cc4ccccc4)c3)cc2s1		CHEMBL4453780	>	IC50	nM	1000.0	CHEMBL1795199	Homo sapiens	IC50	nM	1000.0
	19146693	CHEMBL4378725	Inhibition of recombinant RIPK3 (unknown origin) using MBP as substrate preincubated for 15 mins followed by addition of MBP and measured after 120 min ADP-Glo kinase assay	B	CC(=O)Nc1nc2ccc(-c3cnc(C)c(CC(=O)OC4CCCCC4)c3)cc2s1		CHEMBL4464023	>	IC50	nM	1000.0	CHEMBL1795199	Homo sapiens	IC50	nM	1000.0
	19146701	CHEMBL4378731	Inhibition of recombinant GST-tagged RIPK3 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 4 hrs by ADP-Glo assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	1.6	CHEMBL1795199	Homo sapiens	IC50	nM	1.6
	19146702	CHEMBL4378731	Inhibition of recombinant GST-tagged RIPK3 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 4 hrs by ADP-Glo assay	B	Cc1ccc(CCCCN2C(=O)N[C@H](Cc3c[nH]c4c(Cl)cccc34)C2=O)cc1C#Cc1cnc2cccnn12		CHEMBL4464634	>	IC50	nM	1000.0	CHEMBL1795199	Homo sapiens	IC50	nM	1000.0
	19146732	CHEMBL4378747	Inhibition of human full length N-terminal GST-tagged RIPK3 expressed in baculovirus infected sf9 insect cells assessed as reduction in MBP phosphorylation using MBP as substrate by kinase-Glo luminescence assay	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	IC50	nM	250.0	CHEMBL1795199	Homo sapiens	IC50	nM	250.0
	19146733	CHEMBL4378747	Inhibition of human full length N-terminal GST-tagged RIPK3 expressed in baculovirus infected sf9 insect cells assessed as reduction in MBP phosphorylation using MBP as substrate by kinase-Glo luminescence assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	14520.0	CHEMBL1795199	Homo sapiens	IC50	nM	14520.0
	19146734	CHEMBL4378748	Inhibition of human RIPK3 using MBP as substrate by [gamma33-ATP] based radiometric assay	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	IC50	nM	2.0	CHEMBL1795199	Homo sapiens	IC50	nM	2.0
	19146744	CHEMBL4378755	Binding affinity to human RIPK3 by kinome scan based method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	6700.0	CHEMBL1795199	Homo sapiens	Kd	nM	6700.0
	19146745	CHEMBL4378755	Binding affinity to human RIPK3 by kinome scan based method	B	Nc1nccnc1C(=O)O[C@@H](C(=O)Nc1ccc(F)cc1)c1ccccc1		CHEMBL4440337	>	Kd	nM	30000.0	CHEMBL1795199	Homo sapiens	Kd	nM	30000.0
	19146752	CHEMBL4378760	Inhibition of RIPK3 in human HT-29 cells assessed as reduction in TSZ-induced necroptosis by Cell Titer Glo assay	B	CC(=O)O[C@@H]1CCC(C)(C)[C@H]2C[C@@H](O)C3=C[C@@H](CCC(=O)[C@]12C)[C@H](C)C3=O		CHEMBL4569395	=	IC50	nM	200.0	CHEMBL1795199	Homo sapiens	IC50	uM	0.2
	19266594	CHEMBL4405544	Inhibition of wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL1795199	Homo sapiens	INH	%	50.0
	19271959	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4540715	=	Kd	nM	77.0	CHEMBL1795199	Homo sapiens	Kd	nM	77.0
Not Determined	19271960	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1ccccc1C(F)(F)F)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4535384		Kd			CHEMBL1795199	Homo sapiens	Kd		
	19271961	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1cccc(C(F)(F)F)c1F)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4553409	=	Kd	nM	99.0	CHEMBL1795199	Homo sapiens	Kd	nM	99.0
	19271962	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1ccc(F)c(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4438227	=	Kd	nM	130.0	CHEMBL1795199	Homo sapiens	Kd	nM	130.0
Not Determined	19271963	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1cccc(C(F)(F)F)c1Cl)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4538649		Kd			CHEMBL1795199	Homo sapiens	Kd		
Not Determined	19271964	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4437431		Kd			CHEMBL1795199	Homo sapiens	Kd		
	19271965	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	Cc1ccc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)cc1C		CHEMBL4550952	=	Kd	nM	72.0	CHEMBL1795199	Homo sapiens	Kd	nM	72.0
	19271966	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1cccc([N+](=O)[O-])c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4590158	=	Kd	nM	110.0	CHEMBL1795199	Homo sapiens	Kd	nM	110.0
	19271967	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	Cc1cccc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4444744	=	Kd	nM	33.0	CHEMBL1795199	Homo sapiens	Kd	nM	33.0
	19271968	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	COc1cccc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4464579	=	Kd	nM	55.0	CHEMBL1795199	Homo sapiens	Kd	nM	55.0
	19271969	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1cccc(OC(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4439346	=	Kd	nM	120.0	CHEMBL1795199	Homo sapiens	Kd	nM	120.0
Not Determined	19271970	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1cccc(O)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4548286		Kd			CHEMBL1795199	Homo sapiens	Kd		
	19271971	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	N#Cc1cccc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4573380	=	Kd	nM	120.0	CHEMBL1795199	Homo sapiens	Kd	nM	120.0
	19271972	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1cccc(C(F)(F)F)n1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4575736	=	Kd	nM	280.0	CHEMBL1795199	Homo sapiens	Kd	nM	280.0
Not Determined	19271973	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1ccccn1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4530209		Kd			CHEMBL1795199	Homo sapiens	Kd		
	19271974	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Cc1ccc2c(c1)OCO2)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4469480	=	Kd	nM	81.0	CHEMBL1795199	Homo sapiens	Kd	nM	81.0
	19271975	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	Cn1cc(CC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c2ccccc21		CHEMBL4525593	=	Kd	nM	1400.0	CHEMBL1795199	Homo sapiens	Kd	nM	1400.0
	19271976	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(CCc1cccc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4439279	=	Kd	nM	790.0	CHEMBL1795199	Homo sapiens	Kd	nM	790.0
Not Determined	19271977	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Nc1nc2ccc(Oc3ccc(F)c(NC(=O)C4(c5cccc(C(F)(F)F)c5)CC4)c3)cc2s1)C1CC1		CHEMBL4563598		Kd			CHEMBL1795199	Homo sapiens	Kd		
Not Determined	19271978	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Nc1nc2ccc(Oc3ccc(F)c(NS(=O)(=O)c4cccc(C(F)(F)F)c4)c3)cc2s1)C1CC1		CHEMBL4537807		Kd			CHEMBL1795199	Homo sapiens	Kd		
Not Determined	19271979	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Nc1nc2ccc(Oc3ccc(F)c(NCc4ccc5c(c4)OCO5)c3)cc2s1)C1CC1		CHEMBL4561389		Kd			CHEMBL1795199	Homo sapiens	Kd		
Not Determined	19271980	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Nc1nc2ccc(Oc3ccc(F)c(NCc4cccc(C(F)(F)F)c4)c3)cc2s1)C1CC1		CHEMBL4452724		Kd			CHEMBL1795199	Homo sapiens	Kd		
	19271981	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	COc1cccc(NC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4594113	=	Kd	nM	69.0	CHEMBL1795199	Homo sapiens	Kd	nM	69.0
	19271982	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	Cc1cccc(NC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4440432	=	Kd	nM	93.0	CHEMBL1795199	Homo sapiens	Kd	nM	93.0
	19271983	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	CCOC(=O)c1cccc(NC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4454319	=	Kd	nM	72.0	CHEMBL1795199	Homo sapiens	Kd	nM	72.0
	19271984	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	CC(=O)c1cccc(NC(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)ccc2F)c1		CHEMBL4548552	=	Kd	nM	53.0	CHEMBL1795199	Homo sapiens	Kd	nM	53.0
	19271985	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Kd	nM	81.0	CHEMBL1795199	Homo sapiens	Kd	nM	81.0
Active	19272050	CHEMBL4406995	Inhibition of RIPK3 phosphorylation in TNFalpha/smac mimetic/Z-VAD-fmk stimulated human HT-29 cells at 1 uM treated prior to TNFalpha/smac mimetic/Z-VAD-fmk stimulation and measured after 2 to 4 hrs by SDS-PAGE based immunoblot assay	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Active	19272052	CHEMBL4406997	Inhibition of RIPK3 phosphorylation in human HT-29 cells assessed as reduction in TNFalpha/smac mimetic/Z-VAD-fmk-induced necrosome formation at 1 uM treated prior to TNFalpha/smac mimetic/Z-VAD-fmk stimulation and measured after 4 hrs by immunoprecipitation based assay	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
	19272074	CHEMBL4406961	Binding affinity to wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system after 1 hr by quantitative PCR based KINOMEscan assay	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	Kd	nM	105.0	CHEMBL1795199	Homo sapiens	Kd	nM	105.0
	19400700	CHEMBL4425337	Inhibition of human recombinant RIP3 (2 to 328 residues) expressed in baculovirus by ADP-glo assay	B	CNC(=O)c1ccc2c(c1)ncn2-c1ccc(CC(=O)OC(C)(C)C)cc1		CHEMBL4439913	=	IC50	nM	0.3	CHEMBL1795199	Homo sapiens	IC50	nM	0.3
	22423275	CHEMBL4674213	Inhibition of human RIPK3 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	117.99	CHEMBL1795199	Homo sapiens	Activity	%	117.99
	22423276	CHEMBL4674213	Inhibition of human RIPK3 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	99.23	CHEMBL1795199	Homo sapiens	Activity	%	99.23
	22843927	CHEMBL4720913	Inhibition of human RIPK3 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	101.46	CHEMBL1795199	Homo sapiens	Activity	%	101.46
	22844927	CHEMBL4721602	Inhibition of wild-type human partial length RIPK3 (M1 to Q307 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	107.85	CHEMBL1795199	Homo sapiens	Activity	%	107.85
	22977637	CHEMBL4772146	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 insect cells using myelin basic protein as substrate by ADP-Glo assay	B	CCCCNc1nc2ccc([N+](=O)[O-])cc2[nH]1		CHEMBL4776698	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	22977638	CHEMBL4772146	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 insect cells using myelin basic protein as substrate by ADP-Glo assay	B	CCCCNc1nc2cc([N+](=O)[O-])ccc2s1		CHEMBL4796622	>	IC50	nM	10000.0	CHEMBL1795199	Homo sapiens	IC50	uM	10.0
	23120989	CHEMBL4804483	Inhibition of RIPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-25900.0	CHEMBL1795199	Homo sapiens	IC50	uM	-25.9
	23120990	CHEMBL4804483	Inhibition of RIPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-120800.0	CHEMBL1795199	Homo sapiens	IC50	uM	-120.8
	23120991	CHEMBL4804483	Inhibition of RIPK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-33400.0	CHEMBL1795199	Homo sapiens	IC50	uM	-33.4
	23122028	CHEMBL4804665	Inhibition of RIPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL1795199	Homo sapiens	INH	%	0.0
Not Determined	23122029	CHEMBL4804665	Inhibition of RIPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
	23122030	CHEMBL4804665	Inhibition of RIPK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL1795199	Homo sapiens	INH	%	0.0
Not Active	23171221	CHEMBL4814495	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3cnn(C)c3)c(-c3ccc(F)cc3)nc12		CHEMBL4861720		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171222	CHEMBL4814495	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3ccncc3)c(-c3ccc(F)cc3)nc12		CHEMBL3634367		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171223	CHEMBL4814495	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3cccnc3)c(-c3ccc(F)cc3)nc12		CHEMBL4860515		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171224	CHEMBL4814495	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3cncnc3)c(-c3ccc(F)cc3)nc12		CHEMBL4848621		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171225	CHEMBL4814495	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3cnc(N)nc3)c(-c3ccc(F)cc3)nc12		CHEMBL4871059		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171226	CHEMBL4814495	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of ATP measured after 30 mins by ADP-Glo assay	A	CN(C)c1nccn2c(-c3ccc4[nH]ncc4c3)c(-c3ccc(F)cc3)nc12		CHEMBL4866187		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171297	CHEMBL4814505	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP by radiometric assay	A	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N)nccn23)n1		CHEMBL4877608		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171298	CHEMBL4814505	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP by radiometric assay	A	Nc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N)nccn23)n1		CHEMBL4853288		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171299	CHEMBL4814505	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP by radiometric assay	A	CSc1nccc(-c2c(-c3ccccc3)nc3c(Cl)nccn23)n1		CHEMBL4875029		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171300	CHEMBL4814505	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP by radiometric assay	A	CSc1nccc(-c2c(-c3ccccc3)nc3c(N(C)C)nccn23)n1		CHEMBL4872681		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171301	CHEMBL4814505	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP by radiometric assay	A	CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccccc3)nc12		CHEMBL4860872		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171302	CHEMBL4814505	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP by radiometric assay	A	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL4851634		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171303	CHEMBL4814505	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP by radiometric assay	A	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3c(N(C)C)nccn23)n1		CHEMBL4875986		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Not Active	23171304	CHEMBL4814505	Inhibition of recombinant human RIPK3 expressed in baculovirus infected Sf9 cells using MBP as substrate in presence of [gamma-33P]ATP by radiometric assay	A	CN(C)c1nccn2c(-c3ccnc(N)n3)c(-c3ccc(F)cc3)nc12		CHEMBL4870529		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
	23183194	CHEMBL4817022	Binding affinity to human wild type RIPK3 (M1/Q307) expressed in bacterial expression system by Kinomescan method	B	O=S1(=O)CC2(OCCO2)c2cc3nccc(Nc4ccc5scnc5c4)c3cc21		CHEMBL4861646	=	Kd	nM	7.2	CHEMBL1795199	Homo sapiens	Kd	nM	7.2
Not Active	23183196	CHEMBL4817024	Inhibition of human RIPK3 using ATP and substrate at 0.3 uM incubated for 120 mins by ADP-glo based luminescence assay	B	O=S1(=O)CC2(OCCO2)c2cc3nccc(Nc4ccc5scnc5c4)c3cc21		CHEMBL4861646		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
	23211160	CHEMBL4822734	Inhibition of human wild type RIPK3 (M1 to Q307) expressed in bacterial system by kinomescan assay	B	CC1(C)CC1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4860842	=	Kd	nM	270.0	CHEMBL1795199	Homo sapiens	Kd	nM	270.0
	23211161	CHEMBL4822734	Inhibition of human wild type RIPK3 (M1 to Q307) expressed in bacterial system by kinomescan assay	B	CC1(C)C[C@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4869920	=	Kd	nM	650.0	CHEMBL1795199	Homo sapiens	Kd	nM	650.0
	23211162	CHEMBL4822734	Inhibition of human wild type RIPK3 (M1 to Q307) expressed in bacterial system by kinomescan assay	B	CC1(C)C[C@@H]1C(=O)Nc1nc2ccc(Oc3ccc(F)c(NC(=O)Cc4cccc(C(F)(F)F)c4)c3)cc2s1		CHEMBL4850219	=	Kd	nM	145.0	CHEMBL1795199	Homo sapiens	Kd	nM	145.0
	23211163	CHEMBL4822734	Inhibition of human wild type RIPK3 (M1 to Q307) expressed in bacterial system by kinomescan assay	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	Kd	nM	105.0	CHEMBL1795199	Homo sapiens	Kd	nM	105.0
	23211164	CHEMBL4822734	Inhibition of human wild type RIPK3 (M1 to Q307) expressed in bacterial system by kinomescan assay	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4540715	=	Kd	nM	77.0	CHEMBL1795199	Homo sapiens	Kd	nM	77.0
Active	23303826	CHEMBL4842519	Inhibition of RIPK3 phosphorylation in Z-VAD-fmk (TSZ)-induced human HT-29 cells at 1 uM measured up to 4 hrs by immunoblotting analysis	B	CN1C(=S)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4871408		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Active	23303827	CHEMBL4842519	Inhibition of RIPK3 phosphorylation in Z-VAD-fmk (TSZ)-induced human HT-29 cells at 1 uM measured up to 4 hrs by immunoblotting analysis	B	CN1C(=S)[C@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4872011		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Dose-Dependent Effect	23303832	CHEMBL4842522	Inhibition of RIPK3 phosphorylation in Z-VAD-fmk (TSZ)-induced human HT-29 cells measured at 4 hrs by immunoblotting analysis	B	CN1C(=S)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4871408		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Dose-Dependent Effect	23303833	CHEMBL4842522	Inhibition of RIPK3 phosphorylation in Z-VAD-fmk (TSZ)-induced human HT-29 cells measured at 4 hrs by immunoblotting analysis	B	CN1C(=S)[C@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4872011		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Active	23303838	CHEMBL4842525	Inhibition of RIPK3 in Z-VAD-fmk (TSZ)-induced human HT-29 cells assessed as reduction in RIPK1-RIPK3 necrosome formation at 1 uM measured after 6 hrs by Western blot analysis	B	CN1C(=S)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4871408		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
Active	23303839	CHEMBL4842525	Inhibition of RIPK3 in Z-VAD-fmk (TSZ)-induced human HT-29 cells assessed as reduction in RIPK1-RIPK3 necrosome formation at 1 uM measured after 6 hrs by Western blot analysis	B	CN1C(=S)[C@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21		CHEMBL4872011		Inhibition	%		CHEMBL1795199	Homo sapiens	INH		
	23372878	CHEMBL4884843	RIPK3(RIP3IGRI) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL1795199	Homo sapiens	pIC50		6.0
	23373287	CHEMBL4885134	RIPK3(RIP3IGRI) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL1795199	Homo sapiens	pIC50		6.0
	23373643	CHEMBL4885420	RIPK3(RIP3IGRI) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL1795199	Homo sapiens	pIC50		6.0
Not Active	23383660	CHEMBL4887316	RIPK3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	100.0	CHEMBL1795199	Homo sapiens	% Ctrl	%	100.0
